Arcutis Biotherapeutics, Inc.

ARQT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$71,335$88,398$53,641$97,991
Short-Term Investments$156,620$183,463$355,948$290,610
Receivables$73,066$25,807$8,458$362
Inventory$14,526$13,134$7,514$0
Other Curr. Assets$20,273$19,629$11,845$13,810
Total Curr. Assets$335,820$330,431$437,406$402,773
Property Plant & Equip (Net)$2,994$3,900$4,602$5,301
Goodwill$0$0$0$0
Intangibles$9,479$6,438$7,188$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$596$596$78$78
Total NC Assets$13,069$10,934$11,868$5,379
Other Assets$0$0$0$0
Total Assets$348,889$341,365$449,274$408,152
Liabilities
Payables$14,220$11,992$8,827$7,353
Short-Term Debt$820$735$1,314$433
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$65,973$33,941$27,666$25,540
Total Curr. Liab.$81,013$46,668$37,807$33,326
LT Debt$109,765$205,181$201,886$77,124
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$570$849$0$25
Total NC Liab.$110,335$206,030$201,886$77,149
Other Liabilities$0$0$0$0
Cap. Leases$3,382$4,117$4,774$4,774
Total Liabilities$191,348$252,698$239,693$110,475
Equity
Pref Stock$0$0$0$0
Common Stock$12$9$6$5
Retained Earnings-$1,121,943-$981,904-$719,764-$408,306
AOCI-$7$4-$1,086-$255
Other Equity$1,279,479$1,070,558$930,425$706,233
Total Equity$157,541$88,667$209,581$297,677
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$348,889$341,365$449,274$408,152
Net Debt$39,250$117,518$149,559-$20,434